Liminatus Pharma

LIMN · NASDAQ

$3.22+$0.11 (+3.54%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $3.11

Who owns LIMN

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 0.6% of LIMN’s shares.

Valetudo Therapeutics LLC0.2%
Ewon Comfortech Co Ltd0.1%
Samda Biolab Co, Ltd0.1%
Feelux Co Ltd0.1%
Next 6 largest institutions0.1%
All other shareholders99.4%

Top institutional holders of LIMN
Holder	Shares	% of shares	Change, last filing	Filed
Valetudo Therapeutics LLC	104.89K	0.16%	+68.97K	Jul 2, 2026
Ewon Comfortech Co Ltd	87.47K	0.13%	−22.53K	Jul 2, 2026
Samda Biolab Co, Ltd	68.53K	0.10%	+68.53K	Jul 2, 2026
Feelux Co Ltd	53.33K	0.08%	+0	Jun 23, 2026
Iris Acquisition Holdings LLC	50.60K	0.08%	+0	Jun 23, 2026
Cygnus Capital Advisors, LLC	6.59K	0.01%	−413	Jun 30, 2026
XTX Markets LLC	4.44K	0.01%	+4.44K	Jun 30, 2026
Geode Capital Management, L.L.C.	2.77K	0.00%	+412	Jun 30, 2026
Citadel Advisors LLC	1.12K	0.00%	−12.43K	Jun 30, 2026
Vanguard Capital Management, LLC	1.01K	0.00%	+0	Jun 30, 2026

Largest mutual fund holders

Top mutual fund holders of LIMN
Holder	Shares	% of shares	Change, last filing	Filed
Fidelity Extended Market Index Fund	2.41K	0.00%	+0	Jul 31, 2026
Vanguard Extended Market Index Fund	1.01K	0.00%	+0	Jul 31, 2026
Fidelity Total Market Index Fund	162	0.00%	+0	Jul 31, 2026
Fidelity Series Total Market Index Fund	124	0.00%	+0	Jul 31, 2026

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of LIMN in the last 6 months.

Latest LIMN insider transactions
Insider	Date	Type	Shares	Price	Value
Valetudo Therapeutics LLC	Jul 2, 2026	Other	3.45M	—	—
Valetudo Therapeutics LLC	Jun 24, 2026	Other	4.37M	—	—

Short interest

Settled Sep 30, 2026

Shares short: 44.57K
Days to cover: 1.82
% of shares outstanding: 0.07%
Average daily volume: 24.51K
Change since last report: −24.2%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.